BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 6426042)

  • 21. [Auranofin and sodium aurothiomalate: a comparative review. I. Physicochemical, pharmacokinetic and pharmacological properties].
    Batlle Gualda E
    Med Clin (Barc); 1985 May; 84(20):834-9. PubMed ID: 3928990
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of auranofin on the radiological progression of joint erosion in rheumatoid arthritis.
    Gofton JP; O'Brien WM
    J Rheumatol Suppl; 1982; 8():169-72. PubMed ID: 6813480
    [No Abstract]   [Full Text] [Related]  

  • 23. [Distribution of gold from aurothiomalate and gold trielthylphosphine in whole blood, lymphocytes and lymphocyte chromatin of patients with chronic polyarthritis].
    Teherani DK; Altmann H; Tausch G; Eberl R
    Wien Klin Wochenschr Suppl; 1984; 156():53-5. PubMed ID: 6442060
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparison of auranofin, gold sodium thiomalate, and placebo in the treatment of rheumatoid arthritis. Subsets of responses.
    Ward JR; Williams HJ; Boyce E; Egger MJ; Reading JC; Samuelson CO
    Am J Med; 1983 Dec; 75(6A):133-7. PubMed ID: 6419595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cells with immunoregulatory function: the human macrophages and the effects of remittive drugs.
    Harth M; Keown PA; Orange J
    J Rheumatol Suppl; 1983 Dec; 11():76-80. PubMed ID: 6230447
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cell-bound gold (CBG) in patients treated with aurothioglucose and with auranofin. A comparison of different methods of determination.
    van Riel PL; Gribnau FW; van de Putte LB
    J Rheumatol; 1983 Aug; 10(4):574-8. PubMed ID: 6413685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Auranofin.
    Davis P
    Clin Rheum Dis; 1984 Aug; 10(2):369-83. PubMed ID: 6239742
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative safety and efficacy of auranofin and parenteral gold compounds: a review.
    Horton RJ
    Scand J Rheumatol Suppl; 1983; 51():100-10. PubMed ID: 6426044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of auranofin and aurothioglucose in the treatment of rheumatoid arthritis: a single blind study.
    van Riel PL; van de Putte LB; Gribnau FW; Macrae KD
    Clin Rheumatol; 1984 Mar; 3 Suppl 1():51-6. PubMed ID: 6432414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gold levels produced by treatment with auranofin and sodium aurothiomalate.
    Lewis D; Capell HA; McNeil CJ; Iqbal MS; Brown DH; Smith WE
    Ann Rheum Dis; 1983 Oct; 42(5):566-70. PubMed ID: 6414387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. beta 2 microglobulin plasma levels reflect disease activity in rheumatoid arthritis.
    Crisp AJ; Coughlan RJ; Mackintosh D; Clark B; Panayi GS
    J Rheumatol; 1983 Dec; 10(6):954-6. PubMed ID: 6420563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanism of action, pharmacology, clinical efficacy and side effects of auranofin. An orally administered organic gold compound for the treatment of rheumatoid arthritis.
    Furst DE
    Pharmacotherapy; 1983; 3(5):284-98. PubMed ID: 6417628
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Rheumatoid arthritis: dimensions of the problem].
    Trojani FT
    Clin Ter; 1985 Jun; 113(6):503-6. PubMed ID: 3928233
    [No Abstract]   [Full Text] [Related]  

  • 34. Distribution of gold in blood following administration of auranofin (SK&F D-39162).
    Walz DT; Griswold DE; DiMartino MJ; Bumbier EE
    J Rheumatol Suppl; 1979; 5():56-60. PubMed ID: 114638
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Treatment of rheumatoid arthritis with the oral gold preparation Auranofin].
    Trnavský K; Zbojanová M
    Cas Lek Cesk; 1982 Nov; 122(45):1382-4. PubMed ID: 6821244
    [No Abstract]   [Full Text] [Related]  

  • 36. Auranofin (Ridaura).
    Med Lett Drugs Ther; 1985 Oct; 27(699):89-90. PubMed ID: 3932827
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of auranofin dose regimen change upon cell-associated gold in rheumatoid arthritic patients.
    Walz DT; Griswold DE; DiMartino MJ; Bumbier EE
    J Rheumatol; 1981; 8(5):829-32. PubMed ID: 6796684
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Auranofin. A preliminary review of its pharmacological properties and therapeutic use in rheumatoid arthritis.
    Chaffman M; Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1984 May; 27(5):378-424. PubMed ID: 6426923
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Possible mechanism of action of drugs in the basic therapy of rheumatoid arthritis: effect on platelet aggregation].
    Fioravanti A; Lolatte V; Giordano N; Frati E; Castagna ML; Morozzi G; Lalumera M; Marcolongo R
    Boll Soc Ital Biol Sper; 1984 May; 60(5):1051-6. PubMed ID: 6432005
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral gold therapy in rheumatoid arthritis: auranofin.
    Am J Med; 1983 Dec; 75(6A):1-164. PubMed ID: 6419590
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.